Condition
Cerebral Disorder
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07324330Not ApplicableRecruiting
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
NCT06841887Recruiting
New Advanced Vascular Imaging Ultrasound Protocols
NCT06993142Not ApplicableNot Yet Recruiting
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
NCT06193252Not ApplicableRecruiting
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
NCT03940014Completed
Pulmonary Arteriovenous Malformations (PAVMs) in Hereditary Haemorrhagic Telangiectasia (HHT)
Showing all 5 trials